Tiagabine Concentration, Serum
NY State Approved Indicates the status of NY State approval and if the test is orderable for NY State clients.
This test is used for monitoring tiagabine therapy. Because tiagabine has a wide therapeutic index and dose-dependent toxicity, routine drug monitoring is not indicated in all patients. Drug monitoring is indicated when initiating concomitant therapy with antiepileptic drug that induce hepatic enzymes and when the patient does not respond to treatment to ascertain whether treatment failure is due to noncompliance or nonresponse to the drug.
Genetics Test Information Provides information that may help with selection of the correct test or proper submission of the test request
Reporting Name A shorter/abbreviated version of the Published Name for a test; an abbreviated test name